LIVE

Serial Number

97357860

Owner

Vanda Pharmaceuticals Inc.

Attorney

Jayme M. Torelli

Filing Date

Apr 11, 2022

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

HETLIOZ (TASIMELTEON) CAPSULES Trademark

Serial Number: 97357860

HETLIOZ (TASIMELTEON) CAPSULES is a trademark filed by Vanda Pharmaceuticals Inc. on April 11, 2022. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Vanda Pharmaceuticals Inc. (104 trademarks)

Suite 300
Rockville, MD 20850

Entity Type: 03

Legal Representation

Attorney of Record

Jayme M. Torelli

173 trademarks filed View all →

Correspondence Address

Jayme M. Torelli HOFFMAN WARNICK LLC

6 Tower Place

1st Floor

ALBANY, NY 12203

United States

Trademark Details

Filing Date

April 11, 2022

Registration Date

Not Registered

Published for Opposition

August 29, 2023

Goods & Services

Pharmaceutical preparations containing tasimelteon for use in the treatment of Autism Spectrum Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Delayed Sleep Phase Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of Jet Lag Disorder; Pharmaceutical preparations containing tasimelteon for use in the treatment of depression; Pharmaceutical preparations containing tasimelteon for use in the treatment of Major Depressive Disorder

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 5, 2026 EXRA

SOU EXTENSION 5 GRANTED

Aug 5, 2026 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 3, 2026 AITU

SOU EXTENSION 5 FILED

Mar 25, 2026 EXT5

SOU TEAS EXTENSION RECEIVED

Mar 25, 2026 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 20, 2025 EXRA

SOU EXTENSION 4 GRANTED

Sep 19, 2025 EX4G

SOU EXTENSION 4 FILED

Sep 19, 2025 EXT4

SOU TEAS EXTENSION RECEIVED

Sep 19, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 3, 2025 EXRA

SOU EXTENSION 3 GRANTED

Jan 3, 2025 EX3G

SOU EXTENSION 3 FILED

Jan 3, 2025 EXT3

SOU TEAS EXTENSION RECEIVED

Jan 2, 2025 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Oct 1, 2024 EXRA

SOU EXTENSION 2 GRANTED

Oct 1, 2024 EX2G

SOU EXTENSION 2 FILED

Oct 1, 2024 EXT2

SOU TEAS EXTENSION RECEIVED

Oct 1, 2024 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 30, 2024 EXRA

SOU EXTENSION 1 GRANTED

Mar 29, 2024 EX1G

SOU EXTENSION 1 FILED

Mar 29, 2024 EXT1

SOU TEAS EXTENSION RECEIVED

Mar 29, 2024 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Oct 24, 2023 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Aug 29, 2023 NPUB

PUBLISHED FOR OPPOSITION

Aug 29, 2023 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Aug 9, 2023 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Jul 26, 2023 CNSA

ASSIGNED TO EXAMINER

Jul 19, 2023 DOCK

TEAS/EMAIL CORRESPONDENCE ENTERED

May 4, 2023 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 4, 2023 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 4, 2023 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Mar 14, 2023 GNRN

NON-FINAL ACTION E-MAILED

Mar 14, 2023 GNRT

NON-FINAL ACTION WRITTEN

Mar 14, 2023 CNRT

EXAMINER'S AMENDMENT ENTERED

Feb 9, 2023 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Feb 9, 2023 GNEN

EXAMINERS AMENDMENT E-MAILED

Feb 9, 2023 GNEA

EXAMINERS AMENDMENT -WRITTEN

Feb 9, 2023 CNEA

ASSIGNED TO EXAMINER

Jan 23, 2023 DOCK

NOTICE OF DESIGN SEARCH CODE E-MAILED

Apr 19, 2022 MDSC

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Apr 18, 2022 NWOS

NEW APPLICATION ENTERED

Apr 14, 2022 NWAP

Related Trademarks

More from this Owner

NEREUS (TRADIPITANT)

NEREUS (TRADIPITANT) CAPSULES

Serial #99839209

NEREUS 85MG (TRADIPITANT) CAPSULES

DELOSRX

QUIMILZA

More in Same Class

LIPI START

Serial #97357099